Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061119) titled 'A cohort study investigating the risk of fibrosis in autoimmune alveolar proteinosis' on April 1.
Study Type:
Observational
Primary Sponsor:
Institute - Chiba University
Condition:
Condition - Autoimmune Pulmonary Alveolar Proteinosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To identify the clinical characteristics and prognostic factors associated with cases that do or do not develop pulmonary fibrosis in Autoimmune Pulmonary Alveolar Proteinosis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Participants must meet all of the following criteria (1) through (3):
1) Patients with autoimmune alveolar proteinosis who participated in the PAGE trial
2) Patients for whom retrospective review of clinical data is possible at each participating institution
3) Patients currently receiving outpatient care at a participating institution who, after receiving a thorough explanation regarding participation in this study and demonstrating full understanding, have provided written informed consent of their own free will
Key exclusion criteria - Individuals who meet any of the following criteria:
1) Individuals who have expressed their refusal to participate in this study through the disclosure documents
2) Individuals whom the principal investigator deems unsuitable for other reasons
Target Size - 40
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 03 Month 09 Day
Date of IRB - 2026 Year 03 Month 09 Day
Anticipated trial start date - 2026 Year 03 Month 09 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069942
Disclaimer: Curated by HT Syndication.
